Dow AgroSciences, Indianapolis IN, will market antibody technologies developed under a 2001 collaboration agreement between its Canadian subsidiary and the National Research Council’s Institute for Biological Sciences. The licence agreement will see the technologies used to reduce the risk of food-borne pathogens by attacking them at the source without the use of traditional antibiotics. FMI: www.dowagro.com/ca....